Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer.

Silencing of miR-137 by aberrant promoter hypermethylation in surgically resected lung cancer. Lung Cancer. 2015 Aug; 89(2):99-103.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.